Katherine A. Eade's Insider Trades & SAST Disclosures
Katherine A. Eade's most recent trade in Harvard Bioscience Inc. was a trade of 45,872 Common Stock done . Disclosure was reported to the exchange on May 21, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Katherine A. Eade.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harvard Bioscience Inc. | Katherine A. Eade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 45,872 | 311,126 (0%) | 0% | 0 | Common Stock | |
| Vaxxinity Inc - Ordinary S... | Katherine A. Eade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 132,352 | 132,352 | - | - | Stock option (right to buy) | |
| Harvard Bioscience Inc. | Katherine A. Eade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 25,554 | 265,254 (0%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | Katherine A. Eade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 38,259 | 239,700 (0%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | Katherine A. Eade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 2,525 | 201,441 (0%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | Katherine A. Eade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2021 | 1,401 | 198,916 (0%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | Katherine A. Eade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 14,400 | 197,515 (0%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | Katherine A. Eade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 14,200 | 183,115 (0%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | Katherine A. Eade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 28,100 | 168,915 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges